Volume 7, Issue 1 (February 2020)                   IJML 2020, 7(1): 1-8 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Hadi N, Namazi F, Ketabchi F, Khosravian F, Ravaghi P, Salehi M. Altered Expression of Circulating miR-377 and miR-98 in Relapsing-remitting Multiple Sclerosis. IJML. 2020; 7 (1) :1-8
URL: http://ijml.ssu.ac.ir/article-1-333-en.html
Medical Genetics Research Center of Genome, Isfahan University of Medical Sciences, Isfahan, Iran.
Abstract:   (623 Views)
Background and Aims: Multiple sclerosis (MS) has been assumed to be a complex and indecipherable disease, and poorly understood with regard to etiology which is characterized by relapses and remissions. The expression of microRNAs (miRNAs) is known to be associated with the regulation of immune responses. Recently, investigations have reported that miRNA expression profiles in blood cells become changed in MS. The aim of this study was to elucidate the alterations in the expression of circulating miR-377 and miR-98 in 60 relapsing-remitting MS (RRMS) patients in comparison with controls.
Materials and Methods: This study was conducted using a quantitative real-time polymerase chain reaction method to explore the expression of circulating miR-377 and miR-98 in peripheral blood mononuclear cells from 60 RRMS patients, 30 of whom were recurring patients, 30 were two months after relapse patients, and 30 others were controls, in order to examine the association of expression level of these miRNAs with RRMS.
Results: Results indicated that the expression of miR-377 significantly increases in recurring patients and two months after relapse patients in comparison with controls (p=0.0017 and p=0.0001, respectively). However, miR-98 demonstrated down regulation in recurring patients and two months after relapse patients (p=0.0002 and p=0.0001, respectively).
Conclusions: It can be concluded that miR-377 and miR-98 may be prospective biomarkers with the potential use for diagnosis of RRMS patients in the future investigations.
Full-Text [PDF 347 kb]   (238 Downloads) |   |   Full-Text (HTML)  (266 Views)  
Type of Study: Research | Subject: Genetics/ Biotechnology
Received: 2019/10/23 | Accepted: 2020/01/13 | Published: 2020/03/1

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2021 CC BY-NC 4.0 | International Journal of Medical Laboratory

Designed & Developed by : Yektaweb